Cirugía del recto TAMIS

Cirugía de recto TAMIS

Rectal surgery TAMIS

C. Nevado García*, M. Labalde Martínez*, D. Alías Jiménez*, P. Peláez Torres*, A. Vivas López*, E. Rubio González*, O. García Villar*, F.J. García Borda*, E. Ferrero Herrero*

* Servicio de Cirugía General, Aparato Digestivo y Trasplante de
     Órganos Abdominales. Unidad de Cirugía Colorrectal.
     Hospital Universitario 12 de Octubre. Madrid (España).

DOI: https://doi.org/10.14679/3508

Resumen:

Introducción: La cirugía transanal mínimamente invasiva (TAMIS) para las lesiones rectales es una técnica con buenos resultados oncológicos y que evita la morbilidad de la escisión total mesorrectal en casos seleccionados. El objetivo de este estudio es analizar los resultados de los pacientes intervenidos mediante TAMIS en nuestro centro hospitalario. Material y métodos: se revisan los pacientes intervenidos mediante TAMIS entre septiembre de 2017 y febrero de 2024 en la unidad de cirugía colorrectal del Hospital 12 de octubre. Analizamos variables clínicas, diagnosticas, anatomopatológicas, técnicas y resultados postoperatorios. Resultados: Se intervinieron un total de 24 paciente de edad media de 68 años predominantemente varones. El tamaño medio fue de 3 cm. y localizadas en recto medio. Se resecaron adenomas y adenocarcinomas en estadio precoz con una morbilidad postoperatoria del 16,7%. El tiempo medio de seguimiento fue de 2 años con una tasa de incontinencia fecal del 12,5% y una recurrencia de la enfermedad del 4,2%. Conclusión: Los datos de nuestro centro se encuentran dentro de lo descrito en la literatura con respecto a los resultados del TAMIS. El futuro va encaminado a ampliar las indicaciones y a incorporar otras plataformas como la cirugía robótica en pacientes seleccionados.
Palabras clave: TAMIS, cáncer de recto, indicaciones, recidiva, resultados.

Abstract:

Introduction: Minimally invasive transanal surgery (TAMIS) for rectal lesions is a technique with good oncological results and avoids the morbidity of total mesorrectal excision in selected cases. The aim of this study is to analyze the results of patients operated on by TAMIS in our hospital. Material and methods: Patients operated on by TAMIS between September 2017 and February 2024 in the colorectal surgery unit of the 12 de Octubre Hospital were reviewed. We analyze clinical, diagnostic, anatomopathological, technical and postoperative results. Results: A total of 24 patients with a mean age of 68 years were operated on, predominantly male. The average size was 3 cm and located in the middle rectus. Early-stage adenomas and adenocarcinomas were resected, with a postoperative morbidity of 16.7%. The median follow-up time was 2 years with a fecal incontinence rate of 12.5% and a disease recurrence of 4.2%. Conclusion: The data from our center are within what is described in the literature regarding the results of TAMIS. The future is aimed at expanding the indications and incorporating other platforms such as robotic surgery in selected patients.
Key words: TAMIS, rectal cancer, indications, recurrence, results.

Bibliografía

1. 1. 1. Atallah S, Albert M, Larach S. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc 2010; 24(9); 2200-2205.
      2. Liu H, Zeng Z, Zhang H, Wu M, Ma D, Wang Q, Xie M, Xu Q, Ouyang J, Xiao Y, Song Y, Feng B, Xu Q, Wang Y, Zhang Y, Hao Y, Luo S, Zhang X, Yang Z, Peng J, Wu X, Ren D, Huang M, Lan P, Tong W, Ren M, Wang J, Kang L; Chinese Transanal Endoscopic Surgery Collaborative (CTESC) Group. Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes from a Multicenter Randomized Controlled Trial. Ann Surg. 2023 Jan 1;277(1):1-6.
      3. Agustín Albillos1 , Fernando Carballo2 , Javier Crespo3, and collaborative research group of the Sociedad Española de Patología Digestiva (SEPD) of the “Libro Blanco sobre el Cribado Poblacional de Cáncer Colorrectal en España” Project. Strategic analysis and recommendations of the Sociedad Española de Patología Digestiva (SEPD) regarding population-based screening programs for colorectal cancer in Spain. Rev Esp Enferm Dig 2024; 116(6):319-329. DOI: 10.17235/reed.2024.10458/2024.
      4. Shaukat A, Kaltenbach T, Dominitz JA, Robertson DJ, Anderson JC, Cruise M, Burke CA, Gupta S, Lieberman D, Syngal S, Rex DK. Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020 Nov;159(5):1916-1934.e2. doi: 10.1053/j.gastro.2020.08.050. Epub 2020 Nov 4. PMID: 33159840.
      5. You YN, Hardiman KM, Bafford A, Poylin V, Francone TD, Davis K, Paquette IM, Steele SR, Feingold DL; On Behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. Dis Colon Rectum. 2020 Sep;63(9):1191-1222. doi: 10.1097/DCR.0000000000001762. PMID: 33216491.
      6. Lee L,Burke JP, de Beche-Adams T, Nasif G, Martin-Perez B, Monson JRT, et al. Transanal Minimally Invasive Surgery for Local Excision of Bening and Malignant Rectal Neoplasia: Outcomes From 200 Consecutive Cases With Midterm Follow Up. Ann Surg 2018 May;267(5):910-6.
      7. Schwab ME, Hernandez S, Watanaskul S, Chern H, Varma M, Sarin A. Comparison of advanced techniques for local excision of rectal lesions: a case series. BMC Surg. 2022 Mar 27;22(1):117. doi: 10.1186/s12893-022-01543-w. PMID: 35346146; PMCID: PMC8962117.
      8. Lossius W, Stornes T, Bernstein TE, Wibe A. Implementation of transanal minimally invasive surgery (TAMIS) for rectal neoplasms: results from a single centre. Tech Coloproctol. 2022 Mar;26(3):175-180. doi: 10.1007/s10151-021-02556-y. Epub 2021 Dec 14. PMID: 34905132; PMCID: PMC8857095.
      9. Clermonts SHEM, van Loon YT, Schiphorst AHW, Wasowicz DK, Zimmerman DDE. Transanal minimally invasive surgery for rectal polyps and selected malignant tumors: caution concerning intermediate-term functional results. Int J Colorectal Dis. 2017 Dec;32(12):1677-1685. doi: 10.1007/s00384-017-2893-6. Epub 2017 Sep 13. PMID: 28905101.
      10. Kang MK, Shin R, Sohn BH, Heo SC. Feasibility and Advantages of Transanal Minimally Invasive Surgery (TAMIS) for Various Lesions in the Rectum. J Minim Invasive Surg. 2020 Mar 15;23(1):36-42. doi: 10.7602/jmis.2020.23.1.36. PMID: 35600726; PMCID: PMC8985647.
      11. Kim MJ, Lee TG. Transanal minimally invasive surgery using laparoscopic instruments of the rectum: A review. World J Gastrointest Surg. 2021 Oct 27;13(10):1149-1165. doi: 10.4240/wjgs.v13.i10.1149. PMID: 34754384; PMCID: PMC8554714.
      12. Piozzi GN, Przedlacka A, Duhoky R, Ali O, Ghanem Y, Beable R, Higginson A, Khan JS. Robotic transanal minimally invasive surgery (r-TAMIS): perioperative and short-term outcomes for local excision of rectal cancers. Surg Endosc. 2024 Jun;38(6):3368-3377. doi: 10.1007/s00464-024-10829-4. Epub 2024 May 6. PMID: 38710889; PMCID: PMC11133047.
      13. Stijns RCH, de Graaf EJR, Punt CJA, et al. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study. JAMA Surg 2019; 154:47.
      14. Rullier E, Rouanet P, Tuech JJ, et al. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomized, open-label, multicentre, phase 3 trial. Lancet 2017; 390: 469.
      15. Bach SP; STAR-TREC Collaborative. Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches. Colorectal Dis. 2022 May;24(5):639-651. doi: 10.1111/codi.16056. Epub 2022 Mar 24. PMID: 35114057; PMCID: PMC9311773.
      16. Berger NF, Sylla P. The Role of Transanal Endoscopic Surgery for Early Rectal Cancer. Clin Colon Rectal Surg. 2022 Feb 28;35(2):113-121. doi: 10.1055/s-0041-1742111. PMID: 35237106; PMCID: PMC8885158.
      17. Menahem B, Alves A, Morello R, Lubrano J. Should the rectal defect be closed following transanal local excision of rectal tumors? A systematic review and meta-analysis. Tech Coloproctol. 2017 Dec;21(12):929-936. doi: 10.1007/s10151-017-1714-9. Epub 2017 Nov 13. PMID: 29134387.
      18. Wang C, Liu X, Wang W, Miao Z, Li X, Liu D, Hu K. Treatment Options for Distal Rectal Cancer in the Era of Organ Preservation. Curr Treat Options Oncol. 2024 Apr;25(4):434-452. doi: 10.1007/s11864-024-01194-4. Epub 2024 Mar 22. PMID: 38517596; PMCID: PMC10997725.
      19. O’Sullivan NJ, Temperley HC, Larkin J, McCormick JJ, Rausa E, McCormick P, Heriot A, Mehigan BJ, Warrier S, Kelly ME. Robotic transanal minimally invasive surgery (R-TAMIS): current evidence in the treatment of early rectal neoplasia. Int J Colorectal Dis. 2024 May 9;39(1):71. doi: 10.1007/s00384-024-04645-4. PMID: 38724801; PMCID: PMC11082025.